New aspects of induction chemotherapy for head and neck cancer: POSTASCO 2011

European Archives of Oto-Rhino-Laryngology

Volumn 269, Issue 11, 2012, Pages 2303-2308

  Mumme, A M ^a   Laban, S ^a   Knecht, R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Biological targets; Carcinoma; Chemotherapy induction; Head and neck; Taxanes

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; CAPECITABINE; CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL; HYDROXYUREA; NANOPARTICLE; PACLITAXEL; PLATINUM; TAXANE DERIVATIVE;

ANEMIA; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CEREBROVASCULAR ACCIDENT; CHEMORADIOTHERAPY; COLITIS; DEEP VEIN THROMBOSIS; DIARRHEA; DRUG RESPONSE; FATIGUE; GOLD STANDARD; HEAD AND NECK CANCER; HEART ARREST; HUMAN; INDUCTION CHEMOTHERAPY; LONG TERM CARE; LYMPHOCYTOPENIA; MOUTH CANCER; MUCOSA INFLAMMATION; NASOPHARYNX CARCINOMA; NAUSEA AND VOMITING; NEUTROPENIA; OROPHARYNX CANCER; PHASE 3 CLINICAL TRIAL (TOPIC); PNEUMONIA; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; INDUCTION CHEMOTHERAPY; TAXOIDS;

EID: 84867253510     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-012-1999-2     Document Type: Review

References (23)

1. (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 324(24):1685-1690
2. Paccagnella A et al (2010) Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. Ann Oncol 21(7):1515-1522
3. Vermorken JB et al (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357(17): 1695-1704
4. Posner MR et al (2007) Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.NEngl JMed 357(17):1705-1715
5. Vermorken JB et al (2011) Long-term results from EORTC24971/TAX323: comparing TPF to PF in patients with unresectable squamous cell carcinoma of the head and neck (SCCHN). ASCO Meeting Abstracts 29(15suppl), p 5530
6. Sher DJ et al (2011) Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324. Int J Radiat Oncol Biol Phys, 2011
7. Paccagnella A et al (2011) Concomitant chemoradiation or RT/cetuximab versus induction TPF followed by chemoradiation or RT/cetuximab in locally advanced head and neck squamous cell carcinoma: a randomized phase III factorial study. ASCO Meeting Abstracts 29(15suppl), p TPS196
8. Forastiere AA et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349(22):2091-2098
9. Caudell JJ et al (2011) Concurrent chemoradiotherapy with or without induction chemotherapy for locally advanced head and neck cancer. ASCO Meeting Abstracts 29(15suppl):5553
10. Fayette J et al (2011) A comparison of neoadjuvant TP (nTP; docetaxel, T; cisplatin, P) versus nTPF in patients with locally advanced head and neck squamous cell carcinoma (LAHNSCC). ASCO Meeting Abstracts 29(15suppl):e16006
11. Adkins D et al (2011) Clinical response rate at primary tumor site (PTS) following a novel induction chemotherapy (IC) regimen of weekly nanoparticle albumin-bound (nab-)paclitaxel and cetuximab with every-3-week cisplatin and 5-FU (ACCF) versus docetaxel, cisplatin, 5-FU, and cetuximab (TPF ? C) in patients with locally advanced head and neck squamous cell carcinoma (HNSCC). ASCO Meeting Abstracts 29(15suppl), p 5560
12. Kuperman DI et al (2011) Safety analysis of a novel induction chemotherapy (IC) regimen of weekly nanoparticle albuminbound (nab-)paclitaxel and cetuximab with every 3 week cisplatin and 5-FU in 30 patients (pts) with locally advanced nonmetastatic head and neck squamous cell carcinoma (HNSCC). ASCO Meeting Abstracts 29(15suppl), p e16025
13. Mercke C et al (2011) Survival, tumor control, and toxicity with TPF before accelerated radiotherapy potentiated with cetuximab for stage III-IV unresectable head and neck cancer: A phase II study. ASCO Meeting Abstracts 29(15suppl), p 5552
14. Lucas ZD et al (2011) Sequential treatment of locally advanced squamous cell carcinoma of the oropharynx (LASCCO) using docetaxel, cisplatin, and 5-fluorouracil (TPF) induction regimen: Retrospective results from a single institution. ASCO Meeting Abstracts 29(15suppl):e16015
15. Atassi B et al (2011) Influence of induction chemotherapy on patients' compliance to radiotherapy in patients with locally advanced head and neck squamous cell carcinoma. ASCO Meeting Abstracts 29(15suppl), p 5558
16. Agbahiwe HC et al (2011) Lymph node density and response to induction TPF in patients with HPV-related head and neck cancer. ASCO Meeting Abstracts 29(15suppl), p 5576
17. Seiwert TY et al (2011) A randomized phase II trial of cetuximab- based induction chemotherapy followed by concurrent cetuximab, 5-FU, hydroxyurea, and hyperfractionated radiation (CetuxFHX), or cetuximab, cisplatin, and accelerated radiation with concomitant boost (CetuxPX) in patients with locoregionally advanced head and neck cancer (HNC). ASCO Meeting Abstracts 29(15suppl), p 5519
18. D'Angelillo RMet al (2011) Induction chemotherapywith cisplatin, 5-fluorouracil, and cetuximab followed by radiotherapy and cetuximad in head and neck cancers: Preliminary results of a modern integrated approach. ASCO Meeting Abstracts 29(15suppl), p e16030
19. Lefebvre J et al (2011) Sequential chemoradiotherapy (SCRT) for larynx preservation (LP): results of the randomized phase II TREMPLIN study. ASCO Meeting Abstracts 29(15suppl), p 5501
20. al-Sarraf M et al (1990) Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study. J Clin Oncol 8(8):1342-1351
21. Hegde UP, Dowsett R, Spiro J (2011) Induction chemotherapy (ICT) containing docetaxel, platinum, and 5 fluorouracil (DPF) regimen in a sequential treatment of locally advanced nasopharyngeal cancer (LANPC): retrospective analysis from a single institution. ASCO Meeting Abstracts 29(15suppl):e16037
22. Ho GF (2011) Induction and concurrent chemoradiotherapy with cetuximab for patients with locally advanced nasopharyngeal carcinoma. ASCO Meeting Abstracts 29(15suppl):e16031
23. Yamouni M et al (2011) A phase II trial of induction chemotherapy with cisplatin, docetaxel, and capecitabine followed by concurrent cisplatin-radiotherapy in advanced nasopharyngeal carcinoma. ASCO Meeting Abstracts 29(15suppl):5543